FibroGen Inc (NASDAQ:FGEN)

13.27
Delayed Data
As of Jul 23
 -0.37 / -2.71%
Today’s Change
13.11
Today|||52-Week Range
57.21
-64.22%
Year-to-Date
Here's Why FibroGen Stock Is Plunging Today
Jul 16 / MotleyFool.com - Paid Partner Content
FibroGen (FGEN) Roxadustat Fails to Win FDA Advisory Panel Vote
Jul 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close13.64
Today’s open13.65
Day’s range13.11 - 13.65
Volume67,699
Average volume (3 months)1,625,527
Market cap$1.3B
Data as of 3:59pm ET, 07/23/2021

Growth & Valuation

Earnings growth (last year)-137.10%
Earnings growth (this year)+31.85%
Earnings growth (next 5 years)-59.04%
Revenue growth (last year)-31.28%
P/E ratioNM
Price/Sales18.90
Price/Book3.11

Competitors

 Today’s
change
Today’s
% change
--Oxford BioMedica PLC0.000.00%
AVXLAnavex Life Sciences...-1.32-5.91%
AMRNAmarin Corporation P...-0.10-2.43%
DBVTDBV Technologies SA+0.39+7.75%
Data as of 4:11pm ET, 07/23/2021

Financials

Next reporting dateAugust 9, 2021
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$176.3M
Annual profit (last year)-$189.3M
Net profit margin-107.36%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Francisco, California

Forecasts